It's about patient choice says Tasmanian doctor who believes magic mushrooms and MDMA can help treat depression and PTSD
The Advocate, 25 March, 2021
A Tasmanian doctor says the state’s mental health crisis would be greatly assisted by MDMA and psilocybin assisted therapies, especially for emergency responders impacted by trauma and those with treatment-resistant illness.
Australian government backs psychedelic drug clinical trials to treat mental illness
The Guardian, 18 March, 2021
$15m grant comes despite TGA’s failure to reschedule MDMA and psilocybin from a prohibited substance to a controlled medicine
The Admiral and the Ecstasy
ABC Conversations, 18 March, 2021
Chris Barrie is convinced that the Australian Government should legalise the clinical use of specific psychedelics to help veterans recovering from trauma.
Government commits $15m for psychedelic drug therapy trials
ABC PM with Linda Mottram, 18 March, 2021
The federal government has committed $15 million for the development of psychedelic drug therapies for mental illness. In clinical trials around the world, MDMA, magic mushrooms and ketamine are showing promising results in treating PTSD and depression. Advocacy groups have welcomed the trials but want the prohibited drugs reclassified so they can be used more readily for psycho-therapy.
Psychedelic therapy: Air force veteran’s wild journey back from the abyss
news.com.au, 18 March, 2021
After 16-and-a-half years in the air force, Michael Raymond had seen it all. But by repressing his feelings, he began to push himself down a dark path. His mental health began to deteriorate even further and he was placed on suicide watch. Ultimately, Michael was healed through psychedelic-assisted therapy.
‘Better treatments’: Government to fund psychedelic drugs trials to treat mental illness
The Sydney Morning Herald, 17 March, 2021
Clinical trials using psilocybin, MDMA and other psychedelic medicines in potential breakthrough therapies for debilitating mental illnesses will be funded by the federal government as part of global efforts to advance innovative treatments.
Former trade minister Andrew Robb supports psychedelic medicines
9News, 17 March, 2021
The use of psilocybin, MDMA and other psychedelic medicines to treat mental illness will soon undergo clinical trials funded by the federal government. It’s backed by former Trade Minister Andrew Robb but not all psychiatrists are convinced.
Australian Government to Spend $15m on Psychedelic Trials
VICE, 17 March, 2021
The Australian government will fund a series of clinical trials into the potential use of psilocybin, MDMA, ketamine and other drugs as treatments for debilitating mental illnesses. The $15 million Innovative Therapies for Mental Illness Grant Opportunity aims to bolster Australian-led research into drug and psychedelic-assisted psychotherapy.
Australian War Memorial expansion better invested in psychedelic-assisted therapy research
The Canberra Times, 14 March, 2021
ACT pill testing advocate David Caldicott has voiced disgust over the $500 million expansion of the Australian War Memorial he said the federal government had “inflicted” on the city, while emerging treatments for post traumatic stress disorder were deemed too hard.
Report with Leigh Sales interviewing Andrew Robb AO, Dr Stuart Saker and more
ABC 7.30, 11 March, 2021
Leigh Sales interviewing Andrew Robb AO, psychiatrist Dr Stuart Saker and patient on psychedelic-assisted therapies to treat mental illness. The segment commences at 21:45
Andrew Robb interviewed by James Valentine, ABC Radio Sydney
Afternoons, 11 March, 2021
The interview commences at 1 hour and 2 minutes.
When pills stopped working, Andrew Robb looked to magic mushroom therapy
ABC News, 11 March, 2021
When his daily pile of antidepressant pills stopped working, former Liberal Party director and trade minister Andrew Robb began researching psychedelic therapy as an option to send his depression into remission.
Suicide warning over denied drugs
The Australian, 09 March, 2021
Delaying mental practitioners access to psilocybin and MDMA could result in a spike in suicides amid an ongoing national mental health crisis, according to advocates for psychedelic-assisted therapy.
Demand For Psychedelics On The Up
AJP, 05 March, 2021
Results from the latest Global Drug Survey, released on Friday, reveal that more people including Australians are turning to psychedelic medicines to self-treat mental illness and emotional distress.
Former Defence chief calls for rescheduling of psychedelic drugs to treat mental illness, PTSD
ABC News, 04 March, 2021
Chris Barrie, a former chief of the Defence Force says psychedelic drugs such psilocybin and MDMA should be rescheduled so they can be used to treat mental health conditions including depression and post-traumatic stress disorder (PTSD).
Medicinal ecstasy, magic mushrooms for veterans with PTSD blocked by TGA
The Daily Telegraph, 17 February, 2021
Medical health specialists have slammed the blocking of medically prescribed psychedelic drugs, including ecstasy, shown to successfully treat PTSD in war veterans.
Read the pdf version here
Health Psychiatrists split over the use of ’shrooms and MDMA to treat mental illness
Crikey, 12 February, 2021
The peak body for psychiatrists — whose submission influenced the TGA’s scheduling decision — has come under fire for its conservative position on psychedelics.
Read the pdf version here
The scientists and shamans of psychedelic retreats
ABC News, 07 February, 2021
There’s a landmark project underway in Melbourne to find out whether psilocybin can be used to improve end-of-life experiences.
The legal and illegal ways people are turning to psychedelics as the drug regulator rejects reclassification bid
ABC News, 04 February, 2021
MMA founders expressed disappointment yesterday at the TGA’s desire to wait until current clinical research is complete before the rescheduling of these controversial medicines is considered.
Could Magic Mushrooms and Ecstasy treat mental health issues?
ABC - Afternoons with Sonya Feldhoff, 04 February, 2021
The idea of using psychedelic drugs to treat mental illness is one that might catch a few people off guard. Executive Director of Mind Medicine Australia, spoke to Sonya Feldhoff in the lead up to this decision about why her organisation is in support of their use.
MDMA and psilocybin not approved for medicinal use in Australia
9 News, 03 February, 2021
The TGA chose not to reschedule MDMA and psilocybin from a prohibited substance (schedule 9) to a controlled medicine (schedule 8).
Health regulator to decide on psychedelics
ABC - RN Breakfast with Fran Kelly, 03 February, 2021
For the past two years a group of prominent Australians – including a former Howard government minister and a former Australian Defence Chief – have been campaigning for greater therapeutic access to psychedelic drugs.
MDMA and psilocybin could be approved for medicinal use in Australia
9News, 02 February, 2021
The campaign to reclassify MDMA and psilocybin has been spearheaded by Mind Medicine Australia (MMA), which submitted the rescheduling applications to the TGA in July 2020.
Interview with Admiral Chris Barrie AC and Peter Hunt AM
3AW RADIO, 02 February, 2021
Listen to the full interview here:
Tania de Jong AM - A Healing Note
Wellbeing Magazine, 28 January, 2021
Read about our Co-Founder Tania de Jong AM’s journey.
TGA to rule on psychedelic medicine access for mental health problems
The Australian, 28 January, 2021
A group of prominent Australians is continuing to push for greater access to psychedelic medicines to treat mental health problems, saying the benefits and cost of inaction are impossible to ignore.
MMA Critique of the Article by Stephen Bright and Martin Williams titled “Will Australia legalise ecstasy and magic mushrooms to treat mental illness? Here’s why it’s still too soon.”
Mind Medicine Australia, 26 January, 2021
An article was published in the Conversation by two researchers criticising MMA’s applications to the TGA to reschedule medical grade psilocybin and medical grade MDMA as part of therapies for treatment resistant Depression and treatment resistant PTSD.
The article contained a significant number of errors, misleading statements and lack of disclosure. To enable our followers to form their own conclusions we have annotated the article to address these statements.
Former Defence Force chief Chris Barrie supports increased accessibility of psychedelic drugs
The Canberra Times, 17 January, 2021
Former Defence Force chief Chris Barrie has given his support to a campaign to increase accessibility of psychedelic medicines for sufferers of mental illness, including MDMA and psilocybin.
Psychedelic substances could help with depression: old drugs as remedy for PTSD
Cairns Post, 02 January, 2021
A Therapeutic Goods Administration decision on psychedelic drugs in the New Year could offer hope to Far Northern sufferers of PTSD and depression.
The full article for members is available here.
MDMA and magic mushrooms to be used to treat Australians with mental health issues
Daily Telegraph, 18 December, 2020
Exclusive: In the first course of its kind in the southern hemisphere, 100 Australian doctors, psychiatrists, psychologists, mental health care nurses, social workers and occupational therapists will be trained and ready to treat patients with party drugs such as MDMA and magic mushrooms.
The full article for members is available here.
Million Ideas Episode 1 - Treating mental illness with psilocybin and MDMA
Million Ideas, 07 December, 2020
This first episode is an interview with Tania De Jong of Mind Medicine Australia a charity helping advance the use of psilocybin and MDMA to treat mental illness.
3 Part Series - National Regulator takes on United Nation’s convention. How psychedelic medicine is becoming a reality in Australia
Cannabis Law Report, 01 December, 2020
This is Part 1 of a 3 part series we will be publishing over the next few weeks about Australia’s place in the ever-quickening world of regulated psilocybin and MDMA penned by Mind Medicine Australia (MMA)
Podcast with Kyle Buller and Joe Moore (USA) from Psychedelics Today and Tania de Jong AM
Psychedelics Today, 24 November, 2020
In this episode, Kyle Buller and Joe Moore (USA) interview singer, speaker, social entrepreneur, and founder of numerous charities and organizations, Tania de Jong AM.
Mind Medicine Australia pushes forward with new partner
Byron Echo, 23 November, 2020
As Mind Medicine Australia awaits the results of a rescheduling application before the Therapeutic Goods Administration to allow psychedelic medications to be used more widely in clinical therapy, the charity organisation has announced a new partnership with the company Emyria.
Unstress Podcast with Tania de Jong AM and Dr Ron Ehrlich
Unstress Podcast, 21 October, 2020
Mind Medicine Australia’s Executive Director and Co-Founder, Tania de Jong AM explains why she established Mind Medicine Australia and how it aims to help alleviate the suffering caused by mental illness in Australia through expanding the treatment options available to medical practitioners and their patients.
Psychedelics as medicine?
Healing Echo, 01 November, 2020
Tania de Jong explained that medicinal psilocybin and medicinal MDMA have been granted ‘breakthrough therapy designation’ by the US Food and Drugs Administration to fast-track the approval process, with Australia likely to follow.
How Psilocybin-Assisted Therapy Changed My Life
Mad in America, 03 October, 2020
Mind Medicine Australia’s Executive Director and Co-Founder, Tania de Jong AM explains why she established Mind Medicine Australia and how it aims to help alleviate the suffering caused by mental illness in Australia through expanding the treatment options available to medical practitioners and their patients.
Podcast with Ari Delashmutt and Tania De Jong AM
Ari Delashmut, Ari in the Air Podcast, 26 September, 2020
In this wide-ranging podcast, Tania de Jong AM speaks to podcast host Ari Delashmutt about the work that Mind Medicine Australia is doing to allow psychedelic treatments for clinical use in Australia.
Investors pile in on psychedelic drugs
Australian Financial Review, 16 September, 2020
After years on the outer, psychedelic drugs are making a comeback as a legitimate treatment for patients with mental illness – and investors are taking notice.
First Official Steps Made To Reschedule Magic Mushrooms And MDMA In Australia
Lad Bible, 16 September, 2020
Researchers have been campaigning for Australian authorities to reschedule some illegal drugs so that they can be investigated for any medicinal benefits. Their efforts have started to pay off as the first official steps have been made to get their legal status changed. Mind Medicine Australia has submitted the first applications to Australia’s Therapeutic Goods Administration (TGA) in order to research psilocybin and MDMA.
Will Australia be the First Country to Reap the Benefits of Psychedelic Medicines? Rescheduling Proposal Submitted to TGA
Psilocybin Alpha, 10 September, 2020
On the 1st of September the nonprofit Mind Medicine Australia submitted a proposal to the Australian Therapeutic Goods Association (TGA), the regulatory body in charge of the island country’s drug scheduling. This proposal was submitted in hopes of reclassifying psilocybin and MDMA from prohibited substances to controlled medicines.
Psychedelics as medicine?
Byron Healing, 09 September, 2020
NSW Greens MP Cate Faehrmann recently hosted an online webinar with Tania de Jong AM and Peter Hunt AM from Mind Medicine Australia, looking at the emerging role of psychedelics in mental health treatment.
Is Psychedelics The Answer to Our Mental Health Crisis?
Mamamia, The Quicky Podcast, 04 September, 2020
In this wide-ranging podcast, Tania de Jong AM relates that studies are being done with psychedelic drugs in various ways hoping that they might be a silver bullet for the treatment of mental illness. Since the widespread use of them in the 1960s and their links to the counterculture of the time, the drugs haven’t been taken seriously – until now.
MDMA and psilocybin considered in Australia for psychotherapy use
Newcastle Herald, 04 September, 2020
A psychiatrist has called for people suffering from treatment-resistant post-traumatic stress disorder [PTSD] to be allowed access to MDMA-assisted psychotherapy. Dr Stuart Saker, whose practice is based in Toronto near Newcastle, NSW, said many of his patients were military veterans and emergency service workers.
Push for hallucinogens to be rescheduled as medicines to treat mental illnesses
Campus Review, 04 September, 2020
Mind Medicine Australia is seeking a rescheduling of psilocybin (the active ingredient in magic mushrooms) and MDMA (or ecstasy) by Australia’s Therapeutic Good Administration (TGA) so they can be potentially used in the treatment of mental illness in the future.
Treating mental illness with mushies and MDMA: The regulator wants to know what you think
ABC, 02 September, 2020
Mind Medicine Australia, a not-for-profit that wants psychiatrists to be able to use these drugs in therapy sessions, has applied to the national health regulator to enable mental health professionals to more easily access these medicines.
Mind Medicine Australia Submits Australian-First Application for the Rescheduling of Psilocybin and MDMA
Mind Medicine Australia, 01 September, 2020
Mind Medicine Australia has submitted Australia’s first applications to the Therapeutic Goods Administration (TGA) to reschedule Psilocybin and MDMAso that they can be more easily used as part of clinical therapies for the treatment of major classes of mental illness.
We’re experiencing a growing mental health crisis. We need more innovative solutions
Pro Bono Australia, 24 August, 2020
Tania de Jong AM, co-founder of charity Mind Medicine Australia, says current treatment options are unable to adequately address the “mental health tsunami” being created by the COVID crisis.
Healing the planet's suffering with plant medicines
Paul Austin, The Third Wave Podcast, 04 August, 2020
In this wide-ranging podcast, Tania de Jong and Paul F. Austin talk about mental health, surviving trauma, the mind-altering power of music, catapulting into the cosmos with psychedelics, kangaroos, and folding umbrellas.
Psychedelic Assisted Psychotherapy with Tania de Jong
Cannabis Radio, 01 August, 2020
Mind Revealing Medicines
The Project, Channel 10, 01 July, 2020
Calls to Beyond Blue have increased by 60% during the COVID-19 crisis. Mind Medicine Australia’s Tania de Jong AM and Dr Prash Puspanathan are interviewed by The Project on the radical need for innovation in mental health treatments now. Joel Harrop, ex-ADF veteran also shares his story and credits these medicines for saving his life.
The Psychedelic Renaissance
Australasian Science, 01 July, 2020
Recent studies are finding that psychedelic medicines are effective treatments for mental health disorders such as depression, anxiety, post-traumatic stress disorder and addiction.
Mind Medicine Australia – Psychedelic Stocks Webinar Presentation
Sharecafe, 25 June, 2020
Peter Hunt AM, Founder, Mind Medicine Australia presents at the ShareCafe Psychedelic Stocks Webinar on June 19, 2020.
Move over medicinal cannabis; the latest in psychedelic drug solutions
Boardroom.MEDIA, 19 June, 2020
Boardroom.Media CEO Will Canty talks to Peter Hunt AM, Chairman of Mind Medicine Australia about the emerging psychedelic sector and its potential in treating mental illness.
How psychedelic drugs could help our veterans
9News, 17 June, 2020
9News can reveal the Department of Veterans’ Affairs (DVA) has met with Mind Medicine Australia to discuss a plan to give ADF veterans and first responders special medical access to psychedelic therapy to treat depression, anxiety, post-traumatic stress disorder, and addiction.
Turn On, Tune In But Don’t Drop Out: The Pending Boom In Psychedelic Medicines
Tim Boreham, Sharecafe, 16 June, 2020
Co-founder of Mind Medicine Australia, Peter Hunt AM is interviewed by Tim Boreham of Sharecafe.
Mind Medicine Australia: Could Psychedelics Solve Our Mental Health Crisis?
HiveLife, 12 June, 2020
Meet Melbourne charity Mind Medicine Australia. They’re tackling depression, anxiety, and PTSD with psychedelic-assisted therapy.
Is MDMA Therapy the modern day answer for our Mental Health?
Tom Tilley, Jan Fran, Annika Smethurst and Jamila Rizvi, The Briefing, 12 June, 2020
Experts are warning Coronavirus will have a huge impact on our mental health. Mind Medicine Australia board member, former Liberal minister Andrew Robb AO discusses the potential of psychedelic drugs to help solve this crisis.
The program starts at 8:18.
The Tripp Report Interview with Tania de Jong AM, Executive Director of Mind Medicine Australia
Zach Haigney, The Tripp Report, 10 June, 2020
Co-founder of Mind Medicine Australia, Tania de Jong AM is interviewed by Zack Haigney of the Tripp Report. Tania speaks about the gaps about the psychedelic landscape Down Under and the mission of Mind Medicine Australia.
Tania de Jong interviewed by the ABC's Libbi Gorr
Libbi Gorr, The Weekend Life, 17 May, 2020
Tania de Jong AM, co-founder and Executive Director of Mind Medicine Australia is interviewed by the ABC’s Libbi Gorr on the history of psychedelic treatments and the progress being made here in Australia to make them available.
Psychedelic therapy is the best thing I've done, but I can't recommend it
60 Minutes Australia, 13 May, 2020
A new organisation, Mind Medicine Australia, is seeking to make treatment available more widely. They’re training therapists so that skilled, experienced professionals can add this tool to their therapy kit.
Australia Gets Psychedelic: Professor David Nutt on the Upcoming International Summit on Psychedelic Therapies for Mental Illness
Wesley Thoricatha, Psychedelic Times, 12 May, 2020
Australian charity Mind Medicine Australia is hosting the first-ever International Summit on Psychedelic Therapies for Mental Illness this coming November in Melbourne.
Holocaust Trauma, Psilocybin and the Fight for Psychedelic Therapy with Tania de Jong
Stuart Preston, Stoned Ape Podcast, 25 April, 2020
In this episode, Tania de Jong, shares her story of trauma stemming from her family’s holocaust survival and her journey into psychedelics, as well as the amazing work she and her husband are doing in the non-profit field of psychedelic therapy. Please enjoy this episode with Tania de Jong.
Tania de Jong interviewed by the ABC's Richard Glover
Richard Glover, ABC Drive, 23 April, 2020
Tania de Jong AM, co-founder and Executive Director of Mind Medicine Australia is interviewed by the ABC’s Richard Glover on the progress of psychedelic treatments in Australia.
Andrew Robb and Tania de Jong: Innovation needed in mental health treatment
Andrew Robb AO and Tania de Jong AM, The Saturday Paper, 18 April, 2020
In the wake of Covid-19, mental health experts are warning the trauma caused by the lockdown, employment loss and anxiety associated with the pandemic could be far higher than the physical health impacts of the virus itself. If we are serious about solving our deepening mental health crisis, we need to focus on innovation in treatments as an urgent priority.
Mind Medicine Australia urges psychedelic drugs for mental health treatment during COVID-19
Steve Austin, Drive, , 16 April, 2020
The ABC’s Steve Austin interviews Mind Medicine Australia’s, Andrew Robb AO on the psychological toll the COVID-19 pandemic is having on individuals and the use of Psychedelic medicines to treat mental health illnesses such as depression during the coronavirus pandemic.
The interview starts at 39:00 minutes into the program.
Mind Medicine Australia urges psychedelic drugs for mental health treatment during COVID-19
Elizabeth Daoud, 7NEWS, 16 April, 2020
Psychedelic drugs could be used to treat mental health illnesses such as depression during the coronavirus pandemic, if one charity gets its way. Mind Medicine Australia (MMA) believes every Australian living with a mental health illness should have access to psychedelic-assisted psychotherapy.
Coronavirus pandemic could trigger a spike in mental illness — this organisation thinks psychedelic drugs will help
Kevin Nguyen and Paige Cockburn, ABC News, 16 April, 2020
A more drastic approach involving the introduction of psychedelic drugs for therapy is needed to tackle the psychological impact of coronavirus shutdowns in Australia, a mental health charity has warned.
Psychedelic Drugs Could Help Mental Health During COVID-19 Crisis
Brian Carlton: The Spoonman, Triple M, 16 April, 2020
Mind Medicine Australia (MMA) is driving a new campaign to introduce psychedelic drugs for mental health treatment during COVID-19. MMA Board Member and former coalition MP Andrew Robb explains why psychedelic-assisted psychotherapy could be beneficial to Australians struggling during the coronavirus shutdowns across the country.
Scientists say MDMA could help treat mental health in a post-lockdown world
Brit Dawson, DAZED, 15 April, 2020
A charity in Australia has said that psychedelic drugs should be used as treatment to tackle the psychological impact of coronavirus quarantine.
Mind Medicine Australia calls for URGENT Mental Health Innovation Taskforce to tackle the mental health pandemic sparked by Covid-19
Mind Medicine Australia, 01 April, 2020
Mental health charity Mind Medicine Australia (MMA) calls for and strongly supports all recommendations to form a Mental Health Innovation Taskforce to be immediately established in order to guide the government in planning the next steps to manage the increasing mental health pandemic triggered by Covid-19 and the recent bushfires tragedy.
Come on the Trip of Compassion
Mandy Nolan, Byron Echo, 04 March, 2020
Tania de Jong and Peter Hunt are the trailblaizing founders of Mind Medicine Australia, a not for profit organisation committed to promoting the development of research-based and regulatory-approved psychedelic medicines in Australia.
Talking Point: LSD, ecstasy, shrooms can be medicine
Greg Barns, The Mercury, 24 February, 2020
A new attitude to illicit drugs could have huge health benefits.
How A Single Psilohuasca Experience Helped Catapult Australia Into The Psychedelics Space
18 February, 2020
After her first encounter with plant medicines, Tania de Jong decided to devote her life to legalising them.
Mind Medicine Australia celebrates its First Anniversary
Mind Medicine Australia, 12 February, 2020
Today, Mind Medicine Australia turns one year old! In our first year, we have made remarkable progress in growing public awareness of Medicine-Assisted Therapy in Australia.
Lack of Effective Treatment Options for Major Mental Illnesses and the Need for Innovation
Mind Medicine Australia, 20 January, 2020
Submission to the Mental Health Inquiry 2020
Mind Medicine Australia moves on psychedelics
Peter Stilla, Medium, 17 January, 2020
The story of Mind Medicine Australia and the future of psychiatric treatment in Australia began inauspiciously enough.
Premier Melbourne Screenings- Fantastic Fungi
Mind Medicine Australia, 01 January, 2020
Mind Medicine Australia is proud to the present the Melbourne premier of Fantastic Fungi. An exploration of Mycelium that is the very foundation of life on this planet – not only for our species but for so many species on this Earth that we love and we can work with it to restore our planet.
Premier Byron Bay Screening- Trip of Compassion
Mind Medicine Australia, 01 January, 2020
Mind Medicine Australia is thrilled to announce a screening of the acclaimed documentary Trip of Compassion in Byron Bay, NSW.
Richard Nixon’s ‘war on drugs’ claims casualties every day
Andrew Robb, The Australian, 21 November, 2019
Andrew Robb, a former minister for trade and investment and Non- Executive Director of Mind Medicine Australia, considers whether Australian regulators need to get the ball rolling to reclassify psychedelics from the most restrictive drug category to one that accommodates medicinal use. If it works, what have we got to lose?
Andrew Robb tunes in to curative power of psychedelics
Luke Slattery, The Australian,, 20 November, 2019
A raft of reputable studies have shown these and other psychedelics, such as LSD, to be effective in treating severe depression and psychological trauma, as well as addiction.
Media Release from Hon Andrew Robb AO
Non-Executive Director, Mind Medicine Australia, 01 November, 2019
The Hon Andrew Robb announces his appointment to the Board of Mind Medicine Australia.
Banker's magic mushroom experiment pays off
Jill Margo, The Australian Financial Review, 18 October, 2019
Peter Hunt, the former chairman of Greenhill, flew to the Netherlands to take psilocybin. He says “it was like pushing a reset button” on his brain. With partner Tania de Jong, they are funding the use of psychedelics to treat mental illness.
Trip of a lifetime
Fiona Macdonald, Vogue Australia, 01 September, 2019
An increasing number of overstressed and anxious Australians are ditching modern medicine and reaching for psychedelics to treat their mental health.
Psychedelic mental health treatment expected to be approved in Australia within five years
Lisa Martin, The Guardian, 01 July, 2019
Victorian government urged to help fund and establish psychedelic medicine centre
Interview with Paul Liknaitzky, Executive Officer of Mind Medicine Australia
3CR 855MHz, Community Radio, 19 June, 2019
The return of psychedelics
Luke Slattery, The Australian, 13 June, 2019
This clipping is from the July 13 issue of The Australian Digital Edition.
Letter from Dr Simon Longstaff AO
Director, Mind Medicine Australia, 01 June, 2019
Psychedelics to treat mental illness? Australian researchers are giving it a go.
The Conversation, 24 April, 2019
Martin Williams, Monash University, Stephen Bright, Edith Cowan University,
Psychedelic renaissance: could MDMA help with PTSD, depression and anxiety?
The Guardian, 14 April, 2019
The Psychedelic Renaissance
Australian Science, 01 April, 2019
Psychedelics, addiction, and mental health
All in the Mind, ABC Radio National, 24 February, 2019
Australia’s psychedelic drug trial
The Saturday Paper, 23 February, 2019
The Conversation Hour: Ginger Gorman, Martin Williams, and Tania de Jong
The Conversation Hour with Jon Faine (from 35:20), 19 February, 2019
The Trip of a Lifetime - Push to allow psycheledic drugs for medical use
Herald Sun, 14 February, 2019
The push grows for yet another drug to be decriminalised - Interview with Peter Hunt AM and Tania de Jong AM
Neil Mitchell, 3AW, 14 February, 2019
Live interview with Steve Martin and Professor David Nutt re Mind Medicine Australia and Psychedelic Therapy
ABC Radio, 14 February, 2019
Treating mental illness with psychedelic drugs in Australia - Interview with Professor David Nutt
ABC RN Drive, 13 February, 2019
$1m Kicked into campaign for magic mushroom therapy
The Sydney Morning Herald, 09 February, 2019
Mark Braybrook interviews Peter Hunt, Chair of Mind Medicine Australia
4BC Drive, 06 February, 2019